BLRX

BioLineRX
BLRX

Overview Fund Activity

28 hedge funds and large institutions have $13.5M invested in BioLineRX in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
28
Holders Change
+7
Holders Change %
+33.33%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
10
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SCM
1
Sio Capital Management
New York
$7.65M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$1.41M
3
SCM
3
Silverarc Capital Management
Massachusetts
$558K
4
SSA
4
Schonfeld Strategic Advisors
New York
$213K
5
IP
5
Intellectus Partners
California
$113K

Top Sellers

1
Morgan Stanley
1
Morgan Stanley
New York
$1.11M
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
TNB
3
Thomasville National Bank
Georgia
$0
4
RhumbLine Advisers
4
RhumbLine Advisers
Massachusetts
$38K
5
SFS
5
Sowell Financial Services
Arkansas
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Osaic Holdings
26
Osaic Holdings
Arizona
$2K +$1.73K +19 +633%
PNC Financial Services Group
27
PNC Financial Services Group
Pennsylvania
$1K +$1K +8 New
RE
28
RBC Europe
United Kingdom
$36 -$33 – –
Citadel Advisors
29
Citadel Advisors
Florida
– -$124K -1,233 Closed
TNB
30
Thomasville National Bank
Georgia
– -$51K -508 Closed
SFS
31
Sowell Financial Services
Arkansas
– -$1K -5 Closed
1
2